Dindolyl Methane, or DIM as it’s commonly known as, is a well-known supplement used by bodybuilders and other individuals interested in enhancing the size of their muscles. However there have been some recent links to health hazards that DIM can trigger. For instance, DIM can cause serious liver damage if consumed in excess. Another risk is kidney damage, which may result in kidney failure. Many bodybuilders and athletes are worried about the long-term health risks that come with DIM.
To increase testosterone production the majority of people take diindolylmethane supplement. It is well-known that testosterone functions as an androgen. This means that it can cause hormonal changes in tissues. DIM has been proven in studies to mimic the effects of testosterone, as well as other hormones. Since men produce more testosterone than women do Some manufacturers have added diindolylmethane into their products in order to boost their competitiveness in male circles. The theory is that men respond to a product which mimics the effects of natural testosterone.
Many companies advertise DIM as a tumor suppressor. Although diindolylmethane can be effective in reducing the growth of tumors in laboratory animals it was given orally to the animals. To get the same effect in humans, diindolylmethane would have to be consumed in high doses over a prolonged period of time. Also, although the animals tested were cancer free for several years, they all developed liver disease at some point, possibly due to the excessive diindolylmethane being present in their bodies. A doctor can provide you more information about how DIM functions within the body.
The only way to demonstrate that DIM is effective in treating breast carcinoma is to do an experiment where cells from healthy breast cells are exposed to high doses of diindolylmethane for long periods of time. Like all chemicals, there are both pros and cons associated with using it. Its advantages include the capability to mimic hormones. This allows you to create insulin that inhibits cancer cell growth. The downsides are that diindolylmethane also produces a potentially harmful chemical called DMSO. Learn more about dim diindolylmethane benefits here.
One of the most commonly used claims about diindolylmethane’s usage as treatment for various illnesses is that it is an natural, antibacterial, anticancer, and anti-fungal agent. These claims were rejected by the National Institute of Health after an exhaustive review of the supporting research. According to the Institute of Chemical Technology, there were no studies conducted to verify this assertion. In a comprehensive study of the safety profile of the firestone, the Institute of Chemical Safety concluded that the evidence from pharmaceutical companies about the human benefits of diindolylmethane was not reliable.
Van der Goes, et. al. published their findings in the May 2021 issue of the Journal of Toxicology and Environmental Health. identified a variety of potential dangers associated with the use of diindolylmethane, including allergic reactions to the skin, asthma attacks, dizziness, headaches, and respiratory problems. The daily dose recommended for this chemical, which is approximately one tenth of a teaspoon was 0.2 milligrams. It is not clear what the concentration level is when it is compounded with other compounds. Because this substance has not been thoroughly tested, it cannot be considered safe at any point.
The abstract of the view suggests that the use of diindolylmethane (DIEM) in the treatment of cancer is based on the principle of inhibiting the intracellular inhibition of pyruvate metabolite through flavenoids, and thereby stopping the accumulation of oxalates within renal tubule cells and adenine granulocytes. Metabiplicate toxicology studies on the drug have not shown that this chemical could cause overdose. The Food and Drug Administration approved this substance as a prescribed drug in June 1996. According to the FDA the manufacturer of firestone Tincture is currently conducting two major trials in Europe and the United States.
The view abstract also indicates that the use of diindolylmethane (DIEM) in the context of treating cancer is based on the principle of inhibiting the intracellular inhibition of pyruvate’s pyruvate metabolite via flavenoids, and thus preventing accumulation of oxalates in renal tubule cells and Adenine granulocytes. The drug metabiplicate toxicology studies have not demonstrated that this chemical can cause overdose. The Food and Drug Administration approved this substance as a prescribed drug in June 1996. According to the FDA the manufacturer of firestone Tincture is currently completing two major trials in Europe and the United States. According to the FDA the company that makes firestone tincture is in the process of conducting two major trials in Europe and one in the United States.